Syllable

AI-driven healthcare information and assistance

Sunnyvale, California, United States

About Syllable

Syllable.ai focuses on improving the healthcare industry by using artificial intelligence and machine learning technologies. The company provides an enterprise assistant that helps healthcare organizations access information more easily and improve their operations. This tool uses natural language processing to analyze text and voice data, which helps in making better decisions and enhancing patient care. Syllable.ai's services are subscription-based and tailored for healthcare providers, allowing them to access important information about medical practices, diseases, and medications. A significant advantage of Syllable.ai's technology is its ability to lower service costs, with many organizations reporting over a 50% reduction in expenses after implementation. The goal of Syllable.ai is to enhance access to healthcare information and services, ultimately benefiting both patients and providers.

Sunnyvale, CaliforniaHeadquarters
2017Year Founded
$79.5MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
11-50Employees

Risks

Integration with Actium Health may cause operational disruptions if not managed well.
Rapid expansion post-Series C funding could strain resources and affect service quality.
Evolving data privacy regulations may challenge AI and machine learning models.

Differentiation

Syllable uses AI to transform patient-provider communication in healthcare systems.
Their enterprise assistant democratizes access to healthcare information efficiently.
Syllable's solutions reduce service costs by over 50% for healthcare organizations.

Upsides

Syllable's acquisition of Actium Health enhances AI-driven automation solutions.
Recognition as a top digital front door company boosts Syllable's credibility.
$40M Series C funding supports further development of healthcare solutions.

Funding

Total raised$79.47 M
Latest valuation$200.00 M
StageSERIES_C
SERIES B
5/31/2021
$28
$140.00 M
EARLY VC
8/31/2018
$14
$68.50 M